Healthtech Late Stage Investors & VC Firms
847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.
HM Venture Partners
San FranciscoSeed–Late Stage
7 people
iGan Partners
TorontoSeed–Late Stage$365K – $2.2M
7 people
Mutual Capital Partners
ClevelandSeed–Late Stage$1M
4 people
Rittenhouse Ventures
PhiladelphiaSeed–Late Stage$1M – $3M
7 people
Vesper Infrastructure Partners
LondonGrowth–Late Stage
16 people
BVCF
ShanghaiSeries A–Late Stage$5M
18 people
Ellerston Capital
SydneySeries A–Late Stage
18 people
Alpana Ventures
GenevaSeed–Late Stage
10 people
Harmonix Fund
La QuintaPre-Seed–Late Stage
7 people
Equitage Ventures, L.L.C.
DenverPre-Seed–Late Stage$250K – $2.5M
9 people
TBT
SeoulPre-Seed–Late Stage
CVC Asia Pacific (Japan) Kabushiki Kaisha
TokyoSeries B–Late Stage
11 people
Level One Fund
MiamiSeed–Late Stage
5 people
Mérieux Equity Partners
ParisSeed–Late Stage$3.2M – $86M
11 people
Criteria Bio Ventures
BarcelonaSeed–Late Stage
8 people
Dubai Future District Fund
DubaiPre-Seed–Late Stage
17 people
Union Grove Venture Partners
Chapel HillPre-Seed–Late Stage
2 people
Rocket Internet SE
BerlinSeed–Late Stage
10 people
Pender Ventures
VancouverSeed–Late Stage
12 people
aws Gründungsfonds
ViennaPre-Seed–Late Stage$108K – $1.6M
11 people
Scope Capital Advisory
StockholmSeries A–Late Stage$4.3M – $16.2M
11 people
Katalyst Ventures
San FranciscoPre-Seed–Late Stage
12 people
Sound Bioventures
MalmöSeed–Late Stage
9 people
Adenia Partners
Port LouisGrowth–Late Stage
3 people
Related lists
Healthtech Investors & VC Firms (3208)Late Stage Investors & VC Firms (2864)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)
Data sourced from public filings and firms' own websites — see our methodology.









































































